Skip to main content

Prinzipien der Tumorimmunologie

  • Chapter
  • 86 Accesses

Zusammenfassung

Die Entstehung von Tumoren stellt einen multifaktoriellen Prozeß dar, der durch die sequentielle Akkumulation verschiedener genetischer Ereignisse charakterisiert ist. Dies wurde insbesondere durch Arbeiten von Vogelstein und Koautoren belegt, die bei der Entstehung von Dickdarmkarzinomen verschiedene genetische Mechanismen im Verlauf der Adenom-Karzinom-Sequenz beschrieben (Vogelstein et al. 1988; Vogelstein u. Kinzler 1992). Die Aktivierung von Onkogenen und die Inaktivierung von Tumorsuppressorgenen sind Mechanismen, die für die zelluläre Transformation von Bedeutung sind, wobei chemische, virale und physikalische Karzinogene als Auslöser dieser Mechanismen angesehen werden. Untersuchungen der letzten 20 Jahre deuten auf komplexe Interaktionen zwischen Tumorzellen und dem Immunsystem hin. Durch das wachsende Verständnis der molekularen Vorgänge von Zelloberflächenveränderungen auf Tumorzellen und der Charakterisierung von murinen tumorspezifischen Transplantationsantigenen (TSTA) sowie menschlichen Tumorantigenen hat sich der Wissensstand der zellulären Immunreaktionen gegenüber Tumoren und über die Mechanismen von Tumorzellen, sich dem Immunsystem zu entziehen, deutlich verbessert.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Apasov S, Redegeld F, Sitkovsky M (1993) Cell-mediated cytotoxicity: contact and secreted factors. Curr Opin Immunol 5:404–410

    Article  PubMed  CAS  Google Scholar 

  • Arai KL (1990) Cytokines: Coordinators of immune and inflammatory responses. Annu Rev Biochem 59:783–836

    Article  PubMed  CAS  Google Scholar 

  • Arnaiz-Villena A (1993) MHC research: fast forward. Immunol. Today 14:3–5

    CAS  Google Scholar 

  • Barnd DL, Lan MS, Metzgar RS, Finn OJ (1989) Specific tumor histocompatibility complex-unrestricted recognition of tumor-associated mucins by human cytotoxic T cells. Proc Natl Acad Sci USA 86:7159–7163

    Article  PubMed  CAS  Google Scholar 

  • Baskar S, Ostrand-Rosenberg S, Nabawi M, Nadler LM, Freeman GJ, Glimcher LH (1993) Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated major histocompatibility complex class II molecules. Proc Natl Acad Sci USA 90:5687–5690

    Article  PubMed  CAS  Google Scholar 

  • Bernards R (1987) Suppression of MHC gene expression in cancer cells. TIG 3:298–301

    Article  CAS  Google Scholar 

  • Bijlmakers MJ, Ploegh HL (1993) Putting together an MHC class I molecule. Curr Opin Immunol 5:21–26

    Article  PubMed  CAS  Google Scholar 

  • Bjorkman PJ, Saper MA, Samraoui B, Bennett WS (1987) Structure of the human class I histocompatibility antigen HLA-A2. Nature 329:506–512

    Article  PubMed  CAS  Google Scholar 

  • Boon T (1992) Genetic analysis of tumor rejection antigens. Adv Cancer Res 58:177–210

    Article  PubMed  CAS  Google Scholar 

  • Borden EC, Sondel PM (1990) Lymphokines and cytokines as cancer treatment: immunotherapy realized. Cancer 65:800–814

    Article  PubMed  CAS  Google Scholar 

  • Braciale TJ, Trowsdale J (1993) Antigen recognition. Editorial overview: Epitope formation and recognition. Curr Opin Immunol 5:1–2

    Article  Google Scholar 

  • Brichard V, Van der Pel A, Wölfel T, Wölfel C, DePlaen E, Lethe B, Boon T (1993) The tyrosinase gene codes for an antigen recognized by autologous cytolytic T-lymphocytes on HLA-A2 melanomas. J Exp Med 178:489–495

    Article  PubMed  CAS  Google Scholar 

  • Burke F, Naylor SM, Davies B, Balkwill F (1993) The cytokine wall chart. Immunol Today 14:165–169

    Article  PubMed  CAS  Google Scholar 

  • Campbell RD, Trowsdale J (1993) Map of the human MHC. Immunology Today 14:349–352

    Article  PubMed  CAS  Google Scholar 

  • Chen I, Ashe S, Brady W, Hellstrom I, Hellstrom KE, Ledbetter J, McGowan P, Linsley P (1992) Costimulation of antitumor immunity by the B7 counterrecep-tor for the T-lymphocyte molecules CD28 and CTLA-4. Cell 71:1093–1102

    Article  PubMed  CAS  Google Scholar 

  • Clevers H, Alarcon B, Willeman T, Terhorst C (1988) The T cell receptor/ CD3 complex: a dynamic protein ensemble. Annu Rev Immunol 6:629–662

    Article  PubMed  CAS  Google Scholar 

  • Coulie PG, Brichard V, VanPel A, Wölfel T, Schneider J, Traversari C, DePlaen E, Lurquin C, Szikora, JP, Renauld JC, Boon T (1994) Cloning of the gene coding for a shared melanoma antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J Exp Med 180:35–42

    Article  PubMed  CAS  Google Scholar 

  • Cromme FV, Airey J, Heemels MT, Ploegh HL, Keating PJ, Stern PL, Meijer CJLM, Walboomers JMM (1994) Loss of transporter protein, encoded by the TAP-1 gene, is highly correlated with loss of HLA expression in cervical cancer. J Exp Med 179:335–340

    Article  PubMed  CAS  Google Scholar 

  • David-Watine B, Israel A, Kourilsky P (1990) The regulation of MHC class I genes. Immunol Today 11:286–2292

    Article  PubMed  CAS  Google Scholar 

  • Dawson MM (1991) Lymphokines and interleukins. Open Univ Press, Milton, Keynes

    Google Scholar 

  • Ding L, Lalain EN, Reddish M, Koganty R, Wong T, Samuel, J, Yacyskyn, MB, Meikle A, Fung PY, Taylor-Papadimitrou P (1993) Immunogenicity of synthetic peptides related to the core peptide sequence encoded by the human MUC1 mucin gene: effect of immunization on the growth of mammary adenocarcinoma cells transfected with the human MUC1 gene. Cancer Immunol Immunother 36:9–17

    Article  PubMed  CAS  Google Scholar 

  • Disis ML, Calenoff G, McLaughlin G, Murphy AE, Chen W, Groner B, Jeschke M, Lydon N, McGlynn E, Livingston RB (1994) Existent T-cell and antibody immunity to HER/neu protein in patients with breast cancer. Cancer Res 54:16–20

    PubMed  CAS  Google Scholar 

  • Dustin ML, Springer TA (1991). Role of lymphocyte adhesion receptors in transient interactions and cell locomotion. Annu Rev Immunol 9:27–66

    Article  PubMed  CAS  Google Scholar 

  • Epperson DE, Arnold D, Spieß T, Cresswell P, Pober JS, Johnson DR (1992) Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. J Immunol 149:3297–3301

    PubMed  CAS  Google Scholar 

  • Falk K, Rötzschke O (1993) Consensus motifs and peptide ligands of MHC class I molecules. Sem. Immunol 5:81–94

    CAS  Google Scholar 

  • Falk K, Rötzschke O, Stevanovic S, Jung G, Rammensee HG (1991) Allel-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290–296

    Article  PubMed  CAS  Google Scholar 

  • Feizi T (1985) Demonstration by monoclonal antibodies that carbohydrate structuress of glycoprotens and glycolipids are oncodevelopmental antigens. Nature (London) 314:53–57

    Article  CAS  Google Scholar 

  • Finn OJ (1993) Tumor-rejection antigens recognized by T lymphocytes. Curr Opin Immunol 5:701–708

    Article  PubMed  CAS  Google Scholar 

  • Garrido F, Cabrera T, Concha A, Glew S, Ruiz-Cabello F, Stern PL (1993) Natural history of HLA during tumor development. Immunol Today 14:4912–498

    Article  Google Scholar 

  • Gaugler B, van den Eynde B, van der Bruggen P, Romero P, Gaforio JJ, DePlaen E, Lethe B, Brasseur F, Boon T (1994) Human gene MAGE-3 codes for the antigen recongized on a human melanoma by autologous cytolytic T lymphocytes. J Exp Med 179:921–927

    Article  PubMed  CAS  Google Scholar 

  • Glew SS, Stern PL (1992) HLA antigens and cervical carcinoma. Nature 356:22–23

    Article  PubMed  CAS  Google Scholar 

  • Guerder S, Matzinger P (1992) A fail-safe mechanism for maitaining self-tolerance. J Exp Med 176:553–564

    Article  PubMed  CAS  Google Scholar 

  • Harding FA, Allisson JP (1993) CD28-B7 interactions allow the induction of CD8+ T-lymphocytes in the absence of endogenous help. J Exp Med 177:1791-1798

    Article  PubMed  CAS  Google Scholar 

  • Hogg N, Landis RC (1993) Adhesion molecules in cell interactions. Current Opin Immunol. 5:383–390

    Article  CAS  Google Scholar 

  • Houghton AN (1994) Cancer antigens: Immune recognition of self and altered self. J Exp Med 180:1–4

    Article  PubMed  CAS  Google Scholar 

  • Hu J, Kindsvogel W, Busby S, Bailey M, Shi YY, Greenberg PD (1993) An evaluation of the potential to use tumor-associated antigens as targets for antitumor T cell therapy using transgenic mice expressing tumor antigen in normal lymphoid tissues. J Exp Med 177:1681–1690

    Article  PubMed  CAS  Google Scholar 

  • Jerome KR, Barnd DL, Bendt KM, Boyer C, Taylor-Papadimitrou J, McKenzie IFC, Bast RC, Finn OJ (1991) Cytotoxic T-lymphocytes derived from patients with breast adenocarcinoma recognize an epitope present on the protein core of a mucin molecule preferentially expressed by malignant cells. Cancer Res 51:2908–2916

    PubMed  CAS  Google Scholar 

  • Jung S, Schluesener HJ (1991) Human T-lymphocytes recognize a peptide of single point mutated ras proteins. J Exp Med 173:273–276

    Article  PubMed  CAS  Google Scholar 

  • Kägi D, Ledermann B, Bürki K, Seiler P, Odermatt B, Olsen KJ, Podak ER, Zinkernagel RM, Hengartner H (1994) Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31–37

    Article  PubMed  Google Scholar 

  • Kärre K (1993) Natural killer cells and the MHC class I pathway of peptide presentation. Sem. Immunol 5:127–145

    Google Scholar 

  • Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Rivoltini L, Topalian SL, Miki T, Rosenberg SA (1994a) Cloning of the gene coding for shared human melanoma antigen recognized by autologous T cells infiltrating into tumor. Proc Natl Acad Sci USA 91:3515–3521

    Article  PubMed  CAS  Google Scholar 

  • Kawakami Y, Eliyahu S, Sakaguchi K, Robbins PE, Rivoltini L, Yanelli JR, Appella E, Rosenberg SA (1994) Identification of the immunodominant peptides of the MART-1 human melanoma antigen recognized by the majority of HLA-A2 restricted tumor infiltrating lymphocytes. J Exp Med 180:347–352

    Article  PubMed  CAS  Google Scholar 

  • Klein G, Boon T (1993) Tumor immunology: present perspectives. Curr Opin Immunol 5:687–692

    Article  PubMed  CAS  Google Scholar 

  • Klein E, Mantovani A (1993) Action of natural killer cells and macrophages in cancer. Curr Opin Immunol 5:714–718

    Article  PubMed  CAS  Google Scholar 

  • Klitz W (1992) Viruses, cancer and MHC. Nature 356:17–18

    Article  PubMed  CAS  Google Scholar 

  • Knuth A, Wölfel T, Meyer-zum-Büschenfelde KH (1992) T cell responses to human malignant tumors. Cancer Survey 13:39–52

    CAS  Google Scholar 

  • Kroemer G, Martinez AC (1992) Mechanism of self tolerance. Immunol Today 13:401–404

    Article  PubMed  CAS  Google Scholar 

  • Linsley PS, Bradey W, Grosmaire L, Aruffo A, Damle N, Ledbetter J (1991) Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation. J Exp Med 173:721–730

    Article  PubMed  CAS  Google Scholar 

  • Liu Y, Linsley PS (1992) Costimulation of T cell growth. Curr Opin Immunol 4:265–270

    Article  PubMed  CAS  Google Scholar 

  • Ljunggren HG, Kärre K (1990) In search of the,missing self: MHC molecules and NK cell recognition. Immunol Today 11:237–243

    Article  PubMed  CAS  Google Scholar 

  • Lloyd KO (1991) Humoral immune responses to tumor-associated carbohydrate antigens. Sem Cancer Biol 2:421–431

    CAS  Google Scholar 

  • Lurquin C, vanPel A, Mariane B, DePlaen E, Szikora JP, Jannsson C, Reddehase MJ, LeJeune J, Boon T (1989) Structure of the gene tum-transplantation antigen P19A: the mutated exon encodes a peptide recognized with Ld by cytolytic T cells. Cell 58:293–303

    Article  PubMed  CAS  Google Scholar 

  • Mackensen A, Carcelain G, Viel S, Raynal MC, Michalaki H, Triebel F, Bosq J, Hercend T (1994) Direct evidence to support the immunosurveillance concept in a human regressive melanoma. J Clin Invest 93:1397–1402

    Article  PubMed  CAS  Google Scholar 

  • Mandelboim O, Berke G, Fridkin M, Feldman M, Eisenstein M, Eisenbach L (1994) CTL induction by a tumour-associated antigen octapeptide derived from a murine lung carcinoma. Nature 369:67–71

    Article  PubMed  CAS  Google Scholar 

  • Mantovani A, Botazzi B, Colotta F, Sozzani S, Ruco L (1992) The origin and function of tumor associated macrophages. Immunol Today 13:463–464

    Article  Google Scholar 

  • Maudsley DJ, Pound JD (1991) Modulation of MHC antigen expression by viruses and oncogenes. Immunol Today 12:429–431

    Article  PubMed  CAS  Google Scholar 

  • Melief CJM, Kast WM (1993) Potential immunogenicity of oncogene and tumor suppressor gene products. Current Opinion in Immunol 5:709–713

    Article  CAS  Google Scholar 

  • Monaco JJ (1992) A molecular model of MHC class-I-restricted antigen processing. Immunol. Today 13:173–179

    Article  PubMed  CAS  Google Scholar 

  • Monaco JJ (1993) Structure and function of genes in the MHC class II region. Curr Opin Immunol 5:17–20

    Article  PubMed  CAS  Google Scholar 

  • Moretta L, Ciccione E, Moretta A, Höglund P, Öhlén C, Kärre K (1992) Allorecognition by NK cells: nonself or no self? Immunol Today 13:300–306

    Article  PubMed  CAS  Google Scholar 

  • Mueller DL, Jenkins MK, Schwartz RH (1989) Clonal expansion versus functional clonal inactivation a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 7:445–480

    Article  PubMed  CAS  Google Scholar 

  • Murphy DB (1993) T cell mediated immunosuppression. Curr Opin Immunol 5:411–417

    Article  PubMed  CAS  Google Scholar 

  • Neefjes JJ, Momburg F (1993) Cell biology of antigen presentation. Curr Opin Immunol 5:27–34

    Article  PubMed  CAS  Google Scholar 

  • Old L (1977) Cancer immunology. Sci Am 236:62–79

    Article  PubMed  CAS  Google Scholar 

  • O’Rourke AM, Mescher MF (1993) The roles of CD8 in cytotoxic T lymphocyte function. Immunol Today 14:183–187

    Article  PubMed  Google Scholar 

  • Parmiani G (1993) Tumor immunity as autoimmunity: tumor antigens include normal self proteins which stimulate anergic peripheral T cells. Immunol Today 14:536–538

    Article  PubMed  CAS  Google Scholar 

  • Peace DJ, Chen W, Nelson H, Cheever MA (1991) T-cell recognition of transforming proteins encoded by mutated ras proto-oncogenes. J Immunol 146:2059–2065

    PubMed  CAS  Google Scholar 

  • Rajan TV (1987) Is there a role for MHC class I antigens in the elimination of somatic mutants? Immunol Today 8:171–1172

    Article  Google Scholar 

  • Rammensee HG, Falk K, Rötzschk O (1993) MHC molecules as peptide receptors. Curr Opin Immunol 5:35–44

    Article  PubMed  CAS  Google Scholar 

  • Raychaudhuri S, Morrow WJW (1993) Can soluble antigens induce CD8+ cytotoxic T-cell responses. Immunol Today 14:344–345

    Article  PubMed  CAS  Google Scholar 

  • Real FX, Mattes MJ, Houghton AN, Oettgen HF, Lloyd KO, Old LJ (1984) Class I (unique) tumor antigens of human melanoma. Identification of a 90,000 dalton cell surface glycoprotein by autologous antibody. J Exp Med 160:1219–1233

    Article  PubMed  CAS  Google Scholar 

  • Restifo NP, Esquivel F, Kawamaki Y, Yewdell JW, Mule JJ, Rosenberg SA, Bennink JR (1993) Identification of human cancers deficient in antigen processing. J Exp Med 177:265–272

    Article  PubMed  CAS  Google Scholar 

  • Riley E, Olerup O (1992) HLA polymorphisms and evolution. Immunol Today 13:333–335

    Article  PubMed  CAS  Google Scholar 

  • Rötzschke O, Falk K (1994) Origin, structure and motifs of naturally processed MHC class II ligands. Curr Opin Immunol 6:45–51

    Article  PubMed  Google Scholar 

  • Rötzschke O, Falk K, Deres K, Schild H, Norda M, Metzger J, Jung G, Rammensee HG (1990) Isolation and analysis of naturally processed viral peptides as recognized by cytotoxic T-cells. Nature 348:195–197

    Article  Google Scholar 

  • Schlichtholz B, Legros Y, Gillet D, Gaillard C, Marty M, Lane D, Calvo F, Soussi T (1992) The immune response to p53 in breast cancer patients is directed against immuno-dominant epitopes unrelated to the mutational hot spot. Cancer Res 52:6380–6384

    PubMed  CAS  Google Scholar 

  • Schlossman SF, Boumseekk L, Gilks W, Harlan JM, Kishimoto, T, Morimoto C, Ritz R, Shaw S, Silverstein RL, Spriner TA, Tedder TF, Todd RF (1993) CD antigens. Blood 83:879–880

    Google Scholar 

  • Schrier PI, Bernards R, Vaessen RTMJ, Houweling A, van der Eb AJ (1983) Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells. Nature 305:771–775

    Article  PubMed  CAS  Google Scholar 

  • Siu G, Clark SP, Yoshikai Y, Malissen M, Yanagi Y, Strauss E, Mak TW, Hood L (1984) The human T cell antigen receptor is encoded by variable, diversity, and joining gene segments that rearrange to generate a complete V gene. Cell 37:393–401

    Article  PubMed  CAS  Google Scholar 

  • Srivastava PS, Udono H, Blachere NE, Li Z (1994) Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenet 39:93–98

    Article  CAS  Google Scholar 

  • Tanaka K, Yoshioka T, Bieberich C, Jay G (1988) Role of the major histocompatibility complex class I antigens in tumor growth and metastasis. Annu Rev Immunol 6:359–380

    Article  PubMed  CAS  Google Scholar 

  • Townsend SE, Allisson JP (1993) Tumor rejection after direct costimulation of CD8+ T cells by B7-transfected melanoma cells. Science 259:368–371

    Article  PubMed  CAS  Google Scholar 

  • Townsend A, Bodmer H (1989) Antigen recognition by class I-restricted T-lymphocytes. Annu Rev Immunol 7:601–624

    Article  PubMed  CAS  Google Scholar 

  • Traversari C, Van der Bruggen P, Luescher IF (1992). A nonapeptide encoded by the human gene MAGE-1 is recognized on HLA-A1 by cytolytic T-lymphocy-tes directed against the tumor antigen MZ2-E. J Exp Med 176:1453–1457

    Article  PubMed  CAS  Google Scholar 

  • Van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, van den Eynde B, Knuth A, Boon TA (1991) Gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science 254:1643–1647

    Article  PubMed  Google Scholar 

  • Van der Bruggen P, Van den Eynde B (1992) Molecular definition of tumor antigens recognized by T-lymphocytes. Curr Opinion Immunol. 4:608–612

    Article  Google Scholar 

  • Vitetta ES, Thorpe PE, Uhr JW (1993) Immunotoxins; magic bullets or misguided missiles. Immunol Today 14. 252–255

    Article  PubMed  CAS  Google Scholar 

  • Vogelstein B, Kinzler KW (1992) p53 function and dysfunction. Cell 70:523–526

    Article  PubMed  CAS  Google Scholar 

  • Vogelstein B, Fearon ER, Hamilton SR, Kern SE, Preisinger AC, Leppert M, Nakamura Y, White R, Smits AMM, Bos JL (1988) Genetic alterations during colorectal tumor development. N Engl J Med 319:525–532

    Article  PubMed  CAS  Google Scholar 

  • Zinkernagel R, Doherty P (1974) Restriction of in vitro T-cell mediated cytotoxicity in lymphocytic choriomeningitis within a syngeneic or semi-allogeneic system. Nature 248:701–702

    Article  PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1996 Springer-Verlag Heidelberg

About this chapter

Cite this chapter

Seliger, B., Huber, C. (1996). Prinzipien der Tumorimmunologie. In: Schmoll, HJ., Höffken, K., Possinger, K. (eds) Kompendium Internistische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-79214-4_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-79214-4_2

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-58370-7

  • Online ISBN: 978-3-642-79214-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics